{"title": "A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19)", "doi": "10.1101/2020.02.14.20023028", "citation_id": "2020.02.14.20023028v3", "date": "2020-03-11", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.14.20023028", "abstract": "<p>To control the spread of Corona Virus Disease (COVID-19), screening large numbers of suspected cases for appropriate quarantine and treatment is a priority. Pathogenic laboratory testing is the diagnostic gold standard but it is time consuming with significant false negative results. Fast and accurate diagnostic methods are urgently needed to combat the disease. Based on COVID-19 radiographical changes in CT images, we aimed to develop a deep learning method that could extract COVID-199s graphical features in order to provide a clinical diagnosis ahead of the pathogenic test, thus saving critical time for disease control. \nMethods:We collected 1,119 CT images of pathogen-confirmed COVID-19 cases along with those previously diagnosed with typical viral pneumonia. We modified the Inception transfer-learning model to establish the algorithm, followed by internal and external validation. \nResults: The internal validation achieved a total accuracy of 89.5% with specificity of 0.88 and sensitivity of 0.87. The external testing dataset showed a total accuracy of 79.3% with specificity of 0.83 and sensitivity of 0.67. In addition, in 54 COVID-19 images that first two nucleic acid test results were negative, 46 were predicted as COVID-19 positive by the algorithm, with the accuracy of 85.2%.\nConclusion: These results demonstrate the proof-of-principle for using artificial intelligence to extract radiological features for timely and accurate COVID-19 diagnosis.</p>", "twitter_description": "To control the spread of Corona Virus Disease (COVID-19), screening large numbers of suspected cases for appropriate quarantine and treatment is a priority. Pathogenic laboratory testing is the diagnostic gold standard but it is time consuming with significant false negative results. Fast and accurate diagnostic methods are urgently needed to combat the disease. Based on COVID-19 radiographical changes in CT images, we aimed to develop a deep learning method that could extract COVID-19's graphical features in order to provide a clinical diagnosis ahead of the pathogenic test, thus saving critical time for disease control. Methods:We collected 1,119 CT images of pathogen-confirmed COVID-19 cases along with those previously diagnosed with typical viral pneumonia. We modified the Inception transfer-learning model to establish the algorithm, followed by internal and external validation. Results: The internal validation achieved a total accuracy of 89.5% with specificity of 0.88 and sensitivity of 0.87. The external testing dataset showed a total accuracy of 79.3% with specificity of 0.83 and sensitivity of 0.67. In addition, in 54 COVID-19 images that first two nucleic acid test results were negative, 46 were predicted as COVID-19 positive by the algorithm, with the accuracy of 85.2%. Conclusion: These results demonstrate the proof-of-principle for using artificial intelligence to extract radiological features for timely and accurate COVID-19 diagnosis.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nNo funding\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nAll data referred to in the manuscript is available.\n\n<https://ai.nscc-tj.cn/thai/deploy/public/pneumonia_ct>", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.14.20023028v3.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.14.20023028v3", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.14.20023028v3.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/03/11/2020.02.14.20023028.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.14.20023028v3", "access_rights": "restricted", "authors": ["Shuai Wang", "Bo Kang", "Jinlu Ma", "Xianjun Zeng", "Mingming Xiao", "Jia Guo", "Mengjiao Cai", "Jingyi Yang", "Yaodong Li", "Xiangfei Meng", "Bo Xu"]}